Search filters

List of works by Paola Meraviglia

96 Week follow-up of HIV-infected patients in rescue with raltegravir plus optimized backbone regimens: a multicentre Italian experience

scientific article

Antiretroviral treatment and age-related comorbidities in a cohort of older HIV-infected patients

scientific article published on 01 November 2006

Atherosclerosis is associated with multiple pathogenic mechanisms in HIV-infected antiretroviral-naive or treated individuals

article

Atypical pharmacokinetics of atazanavir in an HIV-1-infected patient

scientific article published on 07 January 2011

Clinical and genetic factors associated with kidney tubular dysfunction in a real-life single centre cohort of HIV-positive patients

scientific article

Clinical and histologic aspects of chronic delta hepatitis

scientific article published on 01 January 1987

Co-administration of raltegravir reduces daily darunavir exposure in HIV-1 infected patients

scientific article published on 20 September 2011

Comparison of the in vivo pharmacokinetics and in vitro dissolution of raltegravir in HIV patients receiving the drug by swallowing or by chewing

scientific article

Comparison of the pharmacokinetics of raltegravir given at 2 doses of 400 mg by swallowing versus one dose of 800 mg by chewing in healthy volunteers: a randomized, open-label, 2-period, single-dose, crossover phase 1 study

scientific article published on February 2015

Determinants of HIV-1 genotypic resistance to darunavir (TMC114) in a large Italian resistance database (Antiretroviral Resistance Cohort Analysis).

scientific article

Determinants of bone diseases in tenofovir-treated HIV patients.

scientific article published on June 2016

Dolutegravir plasma concentrations according to companion antiretroviral drug: unwanted drug interaction or desirable boosting effect?

scientific article published on 23 December 2016

Effect of cobicistat on tenofovir disoproxil fumarate (TDF): what is true for TAF may also be true for TDF.

scientific article published on 25 September 2017

Effectiveness, durability, and safety of darunavir/ritonavir in HIV-1-infected patients in routine clinical practice in Italy: a postauthorization noninterventional study

scientific article published on 6 May 2016

Eligibility and feasibility of the treatment of chronic hepatitis C in a Cohort of Italian HIV-positive patients at a single HIV reference center.

scientific article published on 2 April 2011

Factors associated with virological success with raltegravir-containing regimens and prevalence of raltegravir-resistance-associated mutations at failure in the ARCA database.

scientific article published on 4 January 2013

Four years data of raltegravir-based salvage therapy in HIV-1-infected, treatment-experienced patients: the SALIR-E Study.

scientific article

HIV-1 A1 Subtype Epidemic in Italy Originated from Africa and Eastern Europe and Shows a High Frequency of Transmission Chains Involving Intravenous Drug Users

scientific article

HIV-1 subtype F1 epidemiological networks among Italian heterosexual males are associated with introduction events from South America ⬇️

scientific article

HIV-HCV co-infection: epidemiology, pathogenesis and therapeutic implications

scientific article

High burden of transmitted HIV-1 drug resistance in Italian patients carrying F1 subtype

article

Hydroxychloroquine drastically reduces immune activation in HIV-infected, antiretroviral therapy-treated immunologic nonresponders

scientific article published on 16 May 2011

Immune activation, apoptosis, and Treg activity are associated with persistently reduced CD4+ T-cell counts during antiretroviral therapy.

scientific article published in August 2010

Inter- and intra-patient variability of raltegravir pharmacokinetics in HIV-1-infected subjects

scientific article published on 29 November 2011

Interpretation of genotypic resistance to predict darunavir/ritonavir failure in antiretroviral experienced patients

scientific article published in February 2012

Limited sampling strategies for the estimation of raltegravir daily exposure in HIV-infected patients.

scientific article published on 7 March 2011

Long-term follow-up of HIV-infected patients in salvage therapy with raltegravir plus optimized background regimens: a multicentre Italian experience

scientific article published on 8 November 2010

Lopinavir/ritonavir treatment in HIV antiretroviral-experienced patients: evaluation of risk factors for liver enzyme elevation.

scientific article published on September 2004

Low body weight in females is a risk factor for increased tenofovir exposure and drug-related adverse events

scientific article (publication date: 2013)

Maraviroc as intensification strategy in HIV-1 positive patients with deficient immunological response: an Italian randomized clinical trial

scientific article

Maraviroc intensification for HIV-1-positive immunological non-responders (INRs) despite virological suppression during HAART

article

Metabolic and kidney disorders correlate with high atazanavir concentrations in HIV-infected patients: is it time to revise atazanavir dosages?

scientific article

No pol mutation is associated independently with the lack of immune recovery in patients infected with HIV and failing antiretroviral therapy

scientific article published on March 2011

Pandemic influenza vaccine in adult HIV-1-infected patients

article

Phylogenetic analysis provides evidence of interactions between Italian heterosexual and South American homosexual males as the main source of national HIV-1 subtype C epidemics

scientific article published on 31 January 2014

Post transfusion hepatitis: comparison between homologous and autologous blood transfusion

scientific article published on May 1, 1992

Predictive factors of hyperlipidemia in HIV-infected subjects receiving lopinavir/ritonavir.

scientific article

Predictive factors of lopinavir/ritonavir discontinuation for drug-related toxicity: results from a cohort of 416 multi-experienced HIV-infected individuals.

scientific article

Prevalence and factors associated with idiopathic hypercalciuria in HIV patients on combination antiretroviral therapy

article

Prevalence of transmitted HIV-1 drug resistance in HIV-1-infected patients in Italy: evolution over 12 years and predictors.

scientific article published on 16 July 2009

Risk factors for indinavir-related renal colic in HIV patients: predictive value of indinavir dose/body mass index.

scientific article published in October 2002

Secondary hyperparathyroidism in HIV patients

article

Tenofovir plasma concentrations in post-menopausal versus pre-menopausal HIV-infected women

scientific article published on 8 January 2013

Transmission of resistant HIV type 1 variants and epidemiological chains in Italian newly diagnosed individuals

scientific article

Update on emergence of HIV-1 resistance to antiretroviral drug classes in an Italian national database: 2007-2009.

scientific article

Virologic failure in an HIV-infected woman given desogestrel for excessive menstrual bleeding.

scientific article published on 3 November 2010

Virological success of lopinavir/ritonavir salvage regimen is affected by an increasing number of lopinavir/ritonavir-related mutations.

scientific article

When food can make the difference: The case of elvitegravir-based co-formulation

scientific article published on 31 August 2016

cART Durability and Causes for Treatment Switching or Discontinuation in HIV-Positive Patients Older Than 50 Years of Age

article

Paulina is supported by:

About Paulina

Help